ES2044033T3 - Nuevos derivados de imidazolidina, a procedimientos para su preparacion, asi como a medicamentos que contienen estos compuestos. - Google Patents

Nuevos derivados de imidazolidina, a procedimientos para su preparacion, asi como a medicamentos que contienen estos compuestos.

Info

Publication number
ES2044033T3
ES2044033T3 ES89122736T ES89122736T ES2044033T3 ES 2044033 T3 ES2044033 T3 ES 2044033T3 ES 89122736 T ES89122736 T ES 89122736T ES 89122736 T ES89122736 T ES 89122736T ES 2044033 T3 ES2044033 T3 ES 2044033T3
Authority
ES
Spain
Prior art keywords
rest
compounds
imidazolidine
procedures
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89122736T
Other languages
English (en)
Inventor
Christos Dr Phil N Tsaklakidis
Elmar Dr Phil Bosies
Michael Dr Rer Nat Schultz
Rainer Dr Rer Nat Haag
Dieter Dr Med Herrmann
Wulf Dr Pahlke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of ES2044033T3 publication Critical patent/ES2044033T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/96—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Lubricants (AREA)

Abstract

EL INVENTO SE REFIERE A UN COMPUESTO DE FORMULA (I) Y (II); TRATA DE UN PROCEDIMIENTO PARA LA PRODUCCION DEL DERIVADO DE IMIDAZOLA Y DESCRIBE UN MEDICAMENTO QUE TIENE ACCION INMUNOSUPRESIVA Y CONTIENE ESTOS COMPUESTOS. SIENDO R1 Y R2 IGUALES O DIFERENTES REPRESENTA HIDROGENO, UN RESTO ALQUILO DE C1 A , UN RESTO ALQUENILO DE C3 A 5, UN RESTO FENILO O CONJUNTAMENTE CON EL ATOMO DE CARBONO COMUN, FORMA UN ANIKLLO SATURADO O INSATURADO DE C3 A 7; R3 Y R4 IGUALES O DIFERENTES SIGNIFICAN HIDROGENO, UN RESTO ALQUILO DE CADENA RECTA O RAMIFICADA DE C1 A 10, UN RESTO ALQUENILO DE CADENA RECTA O RAMIFICADA DE C3 A 7, UN RESTO CICLOALQUENILO DE C3 A 7, FENILO, ARILOALQUILO HETEROARILOALQUILO Y X OXIGENO, AZUFRE O N-H.
ES89122736T 1988-12-13 1989-12-09 Nuevos derivados de imidazolidina, a procedimientos para su preparacion, asi como a medicamentos que contienen estos compuestos. Expired - Lifetime ES2044033T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3841879A DE3841879A1 (de) 1988-12-13 1988-12-13 Neue imidazolidin-derivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten

Publications (1)

Publication Number Publication Date
ES2044033T3 true ES2044033T3 (es) 1994-01-01

Family

ID=6369024

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89122736T Expired - Lifetime ES2044033T3 (es) 1988-12-13 1989-12-09 Nuevos derivados de imidazolidina, a procedimientos para su preparacion, asi como a medicamentos que contienen estos compuestos.

Country Status (19)

Country Link
US (1) US4996219A (es)
EP (1) EP0373542B1 (es)
JP (1) JPH0753717B2 (es)
KR (1) KR950005202B1 (es)
AT (1) ATE77374T1 (es)
AU (1) AU624659B2 (es)
CA (1) CA2005248A1 (es)
DD (1) DD290881A5 (es)
DE (2) DE3841879A1 (es)
ES (1) ES2044033T3 (es)
FI (1) FI895937A7 (es)
GR (1) GR3005325T3 (es)
HU (1) HU205745B (es)
IE (1) IE60540B1 (es)
IL (1) IL92595A (es)
MX (1) MX18632A (es)
NZ (1) NZ231663A (es)
PT (1) PT92542B (es)
ZA (1) ZA899458B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE940525L (en) * 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
US5369119A (en) * 1988-07-28 1994-11-29 Boehringer Mannheim Gmbh Use of imexon as an immune suppressive and pharmaceutical compositions containing imexon
US5447949A (en) * 1991-05-15 1995-09-05 Smithkline Beecham Corporation N-(heteroaryl) imidazolyl-alkenoic acids having angiotension II receptor antagonist activity
TW221689B (es) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
FR2695387B1 (fr) * 1992-09-09 1994-10-21 Adir Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
JP3767511B2 (ja) * 2001-04-26 2006-04-19 東洋紡績株式会社 熱収縮性ポリエステル系フィルムロール
ZA200604579B (en) * 2003-12-08 2007-10-31 Univ Arizona Synergistic anti-cancer compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1038050B (de) * 1955-11-17 1958-09-04 Farmaceutici Italia S A Soc Verfahren zur Herstellung von 5-(3', 4'-Dioxybenzyliden)-Derivaten heterocyclischer Verbindungen
DE2530398A1 (de) * 1975-07-08 1977-01-27 Boehringer Mannheim Gmbh Organische verbindung
AU6740187A (en) * 1986-01-07 1987-07-09 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic compounds, methods for the manufacture of the same and pharmaceutical compositions containing the same
AU2484288A (en) * 1987-09-29 1989-04-18 Taiho Pharmaceutical Co., Ltd. Thiohydantoin compounds
IE940525L (en) * 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents

Also Published As

Publication number Publication date
DE3841879A1 (de) 1990-06-21
HU205745B (en) 1992-06-29
IE60540B1 (en) 1994-07-27
AU4599189A (en) 1990-06-21
IL92595A0 (en) 1990-08-31
CA2005248A1 (en) 1990-06-13
NZ231663A (en) 1992-02-25
FI895937A7 (fi) 1990-06-14
FI895937A0 (fi) 1989-12-12
EP0373542B1 (de) 1992-06-17
JPH0753717B2 (ja) 1995-06-07
IE893959L (en) 1990-06-13
DD290881A5 (de) 1991-06-13
GR3005325T3 (es) 1993-05-24
JPH02204483A (ja) 1990-08-14
KR900009607A (ko) 1990-07-05
MX18632A (es) 1993-11-01
US4996219A (en) 1991-02-26
DE58901697D1 (de) 1992-07-23
HUT52066A (en) 1990-06-28
EP0373542A1 (de) 1990-06-20
KR950005202B1 (ko) 1995-05-19
AU624659B2 (en) 1992-06-18
ATE77374T1 (de) 1992-07-15
IL92595A (en) 1994-06-24
PT92542A (pt) 1990-06-29
ZA899458B (en) 1990-09-26
PT92542B (pt) 1995-09-12

Similar Documents

Publication Publication Date Title
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
ES8602616A1 (es) Procedimiento perfeccionado para la fabricacion de amidas organicas derivadas de los lipidos nitrogenados.
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
MX9207604A (es) Derivados del acido quinolon-carboxilico y del acido naftiridon-carboxilico y procedimiento para su fabricacion.
ES2122076T3 (es) Derivados de nor-acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
ES8505928A1 (es) Un derivado de amina.
ES2040206T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
LV12443A (en) 7-(2-Aminoethyl)-benzothiazolones
ES2083625T3 (es) Derivados de n-feniltiourea y uso farmaceutico de los mismos.
ES2054746T3 (es) Aditivo para piensos estabilizado y procedimiento para su preparacion.
AR013462A1 (es) Nuevos peptidomimeticos para el tratamiento de trastornos oseos, metodos para su produccion y drogas que contienen estos compuestos
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.
ES2056184T3 (es) Derivados del 2-amino-6-cloro-4-nitro-fenol, procedimientos para su preparacion y colorantes para el cabello que contienen dichos derivados como colorantes nitrados directos.
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
ES2102043T3 (es) Derivados de 22-en-25-oxa en la serie de la vitamina d, procedimiento para su preparacion, preparados farmaceuticos que los contienen, asi como su utilizacion en calidad de medicamentos.
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
ES2051954T3 (es) 2-aminotiazoles substituidos.
ES2074530T3 (es) Cicloalquilenazoles, procedimiento para su produccion, preparaciones farmaceuticas que los contienen, y su aplicacion para la preparacion de medicamentos.
ES2051955T3 (es) Compuestos azaalifaticos ciclicos con funcion nitroxi, procedimiento para su produccion y medicamentos que contienen estos compuestos.
ES2052009T3 (es) Compuestos ciclicos que contienen azufre.
ES2039719T3 (es) Procedimiento para preparar un agente terapeutico para el tratamiento de la enfermedad de ulcera peptica.
ES8305349A1 (es) "procedimiento para la fabricacion de derivados de las (tienil-2) y (tienil-3)-2 etilaminas".
ES2157498T3 (es) Derivados de triazol o sus sales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 373542

Country of ref document: ES